# Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia

> **NCT00969072** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 121 (actual)

## Conditions studied

- Benign Prostatic Hyperplasia
- Prostatic Hyperplasia

## Interventions

- **DRUG:** GI198745 0.05mg
- **DRUG:** GI198745 0.5mg
- **DRUG:** GI198745 2.5mg

## Key facts

- **NCT ID:** NCT00969072
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2005-02
- **Final completion:** 2005-02
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2010-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969072, "Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00969072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*